Tomczak P. Cabozantinib in monotherapy and combination therapy for first-line renal cell carcinoma: Patient profiles. OncoReview [Internet]. 2025Jun.30 [cited 2026Jan.14];15(1(57):12-7. Available from: https://www.journalsmededu.pl/index.php/OncoReview/article/view/3361